Covance enters agreement to acquire TRAC Microbiology

Thursday, August 11, 2011 01:35 PM

Covance has entered into a definitive agreement to acquire TRAC Microbiology, a Madison, Wisconsin-based food microbiology and chemistry laboratory. TRAC provides testing, research, auditing, and consulting services to clients ranging from small family businesses to large food-based corporations.

"Microbiology is a key growth engine for Covance’s nutritional chemistry and food safety service offering and an area where we see tremendous opportunity to help our clients protect the global food supply," said James Lovett, Corporate senior vice president, Covance. "The acquisition of TRAC brings new scientific talent to Covance and expands the knowledge base and expertise of our microbiology staff in Madison, Wisconsin, and Battle Creek, Michigan. It also allows us to add new services such as consulting, auditing, and research."

Virginia Deibel will assume the role of director, consulting services, microbiology, at Covance. Deibel will provide consultation services on all aspects of plant operations as they relate to microbial quality and safety, and act as a liaison between clients and the FDA/USDA during product-positive events. 

The TRAC acquisition is the latest example of Covance's continued investment to expand its range of microbiological food safety capabilities and services. In October 2010, Covance opened a nutritional chemistry and food safety laboratory in Battle Creek, Michigan.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs